April 22, 2013
A string of lawsuits over adverse reactions of the lung cancer treatment Iressa (gefitinib) ended with a wall-to-wall victory of the government and AstraZeneca K.K. (AZ), the importer and seller of the drug. The Supreme Court earlier this month turned...read more